Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander A Rumyantsev

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Virology|January 18, 2006
A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient miceAlexander A Rumyantsev, Brian R Murphy, Alexander G Pletnev
Vaccine|August 24, 2005
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeysAlexander A Rumyantsev, Robert M Chanock, Brian R Murphy, et al.
Vaccine|July 13, 2006
Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicityAlexander G Pletnev, David E Swayne, Jim Speicher, et al.
Virology|July 3, 2010
The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genomeAmber R Engel, Alexander A Rumyantsev, Olga A Maximova, et al.
Vaccine|September 14, 2017
A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vectorMaryann Giel-Moloney, Alexander A Rumyantsev, Fred David, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2013
Single-dose vaccine against tick-borne encephalitisAlexander A Rumyantsev, Ana P Goncalvez, Maryann Giel-Moloney, et al.
Virology|November 17, 2009
Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirusAlexander A Rumyantsev, Zhen-xi Zhang, Qing-sheng Gao, et al.
Vaccine|May 31, 2011
Characterization of the RepliVax platform for replication-defective flavivirus vaccinesAlexander A Rumyantsev, Maryann Giel-Moloney, Yuxi Liu, et al.
Journal of Medical Virology|August 22, 2009
Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitisNatalia S Pripuzova, Natalia V Tereshkina, Larissa V Gmyl, et al.
Vaccine|August 19, 2007
Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE)Konstantin V Pugachev, Julia Schwaiger, Nathan Brown, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Virology|January 18, 2006
A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient miceAlexander A Rumyantsev, Brian R Murphy, Alexander G Pletnev
Vaccine|August 24, 2005
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeysAlexander A Rumyantsev, Robert M Chanock, Brian R Murphy, et al.
Vaccine|July 13, 2006
Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicityAlexander G Pletnev, David E Swayne, Jim Speicher, et al.
Virology|July 3, 2010
The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genomeAmber R Engel, Alexander A Rumyantsev, Olga A Maximova, et al.
Vaccine|September 14, 2017
A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vectorMaryann Giel-Moloney, Alexander A Rumyantsev, Fred David, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2013
Single-dose vaccine against tick-borne encephalitisAlexander A Rumyantsev, Ana P Goncalvez, Maryann Giel-Moloney, et al.
Virology|November 17, 2009
Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirusAlexander A Rumyantsev, Zhen-xi Zhang, Qing-sheng Gao, et al.
Vaccine|May 31, 2011
Characterization of the RepliVax platform for replication-defective flavivirus vaccinesAlexander A Rumyantsev, Maryann Giel-Moloney, Yuxi Liu, et al.
Journal of Medical Virology|August 22, 2009
Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitisNatalia S Pripuzova, Natalia V Tereshkina, Larissa V Gmyl, et al.
Vaccine|August 19, 2007
Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE)Konstantin V Pugachev, Julia Schwaiger, Nathan Brown, et al.
Pageof 2